Back to Newsroom

Sigilon Therapeutics to Present at Upcoming Conferences

CAMBRIDGE, Mass.Feb. 8, 2018 /PRNewswire/ — Sigilon Therapeutics, a biopharmaceutical company that discovers and develops immune-privileged living therapeutic implants, today announced that the company will present at the following upcoming conferences.
READ MORE…